Abstract
Advances in techniques of blood and plasma donation, cell separation and preservation as well as new methods for plasma fractionation have made component therapy available in countries with an advanced transfusion service. This has broadened the evergreen subject of use and abuse of whole blood with problems emerging from the clinical use of blood products. Without any attempt to cover this endless subjects, this paper will be focused on some controversial and changing trends in the use of cell concentrates.